Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Richards

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 2, 2018
The Hexavalent CD40 Agonist HERA-CD40L Induces T-Cell-mediated Antitumor Immune Response Through Activation of Antigen-presenting CellsChristian Merz, Jaromir Sykora, Viola Marschall, et al.
Clinical Colorectal Cancer|April 15, 2020
Gastrointestinal Injury Related to Antiangiogenesis Cancer TherapyTenglong Tang, Hamzah Abu-Sbeih, Weijie Ma, et al.
American Journal of Clinical Oncology|June 6, 2021
Clinical Characteristics and Outcomes of Eosinophilic Colitis in Patients With CancerShruti Khurana, Hamzah Abu-Sbeih, Weijie Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2012
The Ser/Thr protein kinase AfsK regulates polar growth and hyphal branching in the filamentous bacteria StreptomycesAntje M Hempel, Stuart Cantlay, Virginie Molle, et al.
Frontiers in Oncology|October 10, 2018
A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor ImmunityMeinolf Thiemann, David M Richards, Karl Heinonen, et al.
Cancers|June 28, 2023
Clinical Features and Management of Acute and Chronic Radiation-Induced Colitis and ProctopathyHamzah Abu-Sbeih, Tenglong Tang, Faisal S Ali, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 8, 2021
Clinicopathologic Features, Treatment Response, and Outcomes of Immune Checkpoint Inhibitor-Related EsophagitisKavea Panneerselvam, Rajan N Amin, Dongguang Wei, et al.
Journal for Immunotherapy of Cancer|July 21, 2019
HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionalityDavid M Richards, Viola Marschall, Katharina Billian-Frey, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|April 1, 2020
Mitochondrial fission factor (MFF) is a critical regulator of peroxisome maturationJosiah B Passmore, Ruth E Carmichael, Tina A Schrader, et al.
American Journal of Clinical Oncology|September 4, 2019
Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell TherapyHamzah Abu-Sbeih, Tenglong Tang, Faisal S Ali, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 2, 2018
The Hexavalent CD40 Agonist HERA-CD40L Induces T-Cell-mediated Antitumor Immune Response Through Activation of Antigen-presenting CellsChristian Merz, Jaromir Sykora, Viola Marschall, et al.
Clinical Colorectal Cancer|April 15, 2020
Gastrointestinal Injury Related to Antiangiogenesis Cancer TherapyTenglong Tang, Hamzah Abu-Sbeih, Weijie Ma, et al.
American Journal of Clinical Oncology|June 6, 2021
Clinical Characteristics and Outcomes of Eosinophilic Colitis in Patients With CancerShruti Khurana, Hamzah Abu-Sbeih, Weijie Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2012
The Ser/Thr protein kinase AfsK regulates polar growth and hyphal branching in the filamentous bacteria StreptomycesAntje M Hempel, Stuart Cantlay, Virginie Molle, et al.
Frontiers in Oncology|October 10, 2018
A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor ImmunityMeinolf Thiemann, David M Richards, Karl Heinonen, et al.
Cancers|June 28, 2023
Clinical Features and Management of Acute and Chronic Radiation-Induced Colitis and ProctopathyHamzah Abu-Sbeih, Tenglong Tang, Faisal S Ali, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 8, 2021
Clinicopathologic Features, Treatment Response, and Outcomes of Immune Checkpoint Inhibitor-Related EsophagitisKavea Panneerselvam, Rajan N Amin, Dongguang Wei, et al.
Journal for Immunotherapy of Cancer|July 21, 2019
HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionalityDavid M Richards, Viola Marschall, Katharina Billian-Frey, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|April 1, 2020
Mitochondrial fission factor (MFF) is a critical regulator of peroxisome maturationJosiah B Passmore, Ruth E Carmichael, Tina A Schrader, et al.
American Journal of Clinical Oncology|September 4, 2019
Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell TherapyHamzah Abu-Sbeih, Tenglong Tang, Faisal S Ali, et al.
Pageof 6